The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Determining an MS Patient's Long-Term Prognosis
Determining an MS Patient's Long-Term Prognosis
Current and Future MS Treatment Options
Current and Future MS Treatment Options
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Emerging MRI Techniques in MS Patients
Emerging MRI Techniques in MS Patients
Current Landscape of MS Diagnosis/Prognosis
Current Landscape of MS Diagnosis/Prognosis
The Value of Biomarkers in MS Patients
The Value of Biomarkers in MS Patients